StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3072% below fair value
$0.16−0.02 (-13.01%)

Close on Nov 20, 2026Market cap $2.01MP/E –Yield –

20/20 Biolabs free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for 20/20 Biolabs

20/20 Biolabs has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More 20/20 Biolabs figures

See a number that looks wrong?